Press Releases

Axsendo Clinical Research (ACR), an emerging national clinical research site network, is thrilled to announce the launch of its first location in Houston, Texas. This state-of-the-art research facility opened in July and will serve as the central hub, supporting satellite locations throughout Houston in partnership with local physicians and practices.

“As an international healthcare and research destination, Houston was a natural choice for launching our hub-and-spoke site network,” said Dominic Doenges, Axsendo Clinical’s SVP of Strategic Partnerships. “Alongside the top physicians in their specialties, our goal is to integrate ourselves within the community, engaging with and creating a premium research experience for a patient population that doesn’t normally get to participate.”

Physician and principal investigator Dr. Aramis Cosme stated, “I am delighted to join Axsendo Clinical at such an exciting time in the company's growth. I look forward to collaborating with the team to further our mission of advancing medical research and delivering innovative treatments to the diverse communities we serve across Houston.”

Axsendo Clinical is committed to advancing medicine across seven core therapeutic areas, beginning locally in Houston and then strengthening through strategic partnerships in other key markets with investigators specializing in Cardiology, Endocrinology, Gastroenterology, Nephrology, Neurology, Pulmonology, and Family Medicine.

ACR expects to access over 500,000 patients in the south Texas market by 2025.